Recent news on Spectracef

Cornerstone BioPharma, Inc. Obtains Exclusive Licensing Rights for ...  09 Nov 2006
...the company has obtained exclusive US licensing rights from leading Japanese pharmaceutical company Meiji Seika Kaisha for Spectracef (cefditoren pivoxil). ... -PR.com (press release), Cornerstone BioPharma, Inc. Obtains Exclusive Licensing Rights for ...  -  Nov 13, 2006
SBWire (press release),Spectracef is a cephalosporin oral antibiotic used to treat adults and adolescents (12 years of age or older) with certain bacterial infections of the lungs

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional